journal article·2022-02-22

Intrinsic Radical Species Scavenging Activities of Tea Polyphenols Nanoparticles Block Pyroptosis in Endotoxin-Induced Sepsis

Yuan Chen, Ruiheng Luo, Jing Li, Shengfeng Wang, Jinsong Ding, Kai Zhao, Ben Lu, Wenhu Zhou

ACS Nano· Volume 16· Issue 2
Publisher page

Abstract

Sepsis, a life-threating illness caused by deregulated host immune responses to infections, is characterized by overproduction of multiple reactive oxygen and nitrogen species (RONS) and excessive pyroptosis, leading to high mortality. However, there is still no approved specific molecular therapy to treat sepsis. Here we reported drug-free tea polyphenols nanoparticles (TPNs) with intrinsic broad-spectrum RONS scavenging and pyroptosis-blocking activities to treat endotoxin (LPS)-induced sepsis in mice. The RONS scavenging activities originated from the polyphenols-derived structure, while the pyroptosis blockage was achieved by inhibiting gasdermin D (GSDMD) mediating the pore formation and membrane rupture, showing multifunctionalities for sepsis therapy. Notably, TPNs suppress GSDMD by inhibiting the oligomerization of GSDMD rather than the cleavage of GSDMD, thus displaying high pyroptosis-inhibition efficiency. As a result, TPNs showed an excellent therapeutic efficacy in sepsis mice model, as evidenced by survival rate improvement, hypothermia amelioration, and the organ damage protection. Collectively, TPNs present biocompatible candidates for the treatment of sepsis.
Source: openalex_inverted_index · Quality: baseline

Research context

OpenAlex topics: Inflammasome and immune disorders · Heme Oxygenase-1 and Carbon Monoxide · Inflammatory Biomarkers in Disease Prognosis

SciVX discovery tags are terminology-based. OpenAlex topics are source-provided classifications.

Affiliations

Xiangya School of Pharmaceutical Sciences, Central South University, Changsha, Hunan 410013, China

Department of Pharmacy, The First People’s Hospital of Changde City, Changde, Hunan 415003, China

Hematology and Department of Critical Care Medicine, The Third Xiangya Hospital, Central South University, Changsha, Hunan 410013, China

Department of Pharmacy, The Third Xiangya Hospital, Central South University, Changsha, Hunan 410013, China

Department of Pathophysiology, School of Basic Medical Science, Central South University, Changsha, Hunan 410000, P. R. China

Key Laboratory of Sepsis and Translational Medicine, School of Basic Medical Science, Central South University, Changsha, Hunan 410000, P. R. China

Funding

Ministry of Science and Technology of the People's Republic of China · Natural Science Foundation of?Hunan Province · National Natural Science Foundation of China · Hunan Province

References (41)

Show source-provided references
1. 10.1136/bmj.i158510.1136/bmj.i1585 ↗
2. 10.1038/s41581-018-0005-710.1038/s41581-018-0005-7 ↗
3. 10.1016/S1473-3099(19)30567-510.1016/S1473-3099(19)30567-5 ↗
4. 10.1016/S0140-6736(15)00473-010.1016/S0140-6736(15)00473-0 ↗
5. 10.1038/s41573-021-00154-z10.1038/s41573-021-00154-z ↗
6. 10.1038/s41577-019-0228-210.1038/s41577-019-0228-2 ↗
7. 10.3389/fimmu.2020.0164910.3389/fimmu.2020.01649 ↗
8. 10.1038/nature1554110.1038/nature15541 ↗
9. 10.1126/sciimmunol.aat273810.1126/sciimmunol.aat2738 ↗
10. 10.1038/s41590-020-0669-610.1038/s41590-020-0669-6 ↗
11. 10.1016/j.redox.2021.10204610.1016/j.redox.2021.102046 ↗
12. 10.1002/anie.20170490410.1002/anie.201704904 ↗
13. 10.1021/acsnano.0c0380710.1021/acsnano.0c03807 ↗
14. 10.1016/j.biopha.2015.12.01310.1016/j.biopha.2015.12.013 ↗
15. 10.1021/acsnano.8b0301910.1021/acsnano.8b03019 ↗
16. 10.1021/acsnano.8b0147010.1021/acsnano.8b01470 ↗
17. 10.1039/D0BM02064H10.1039/D0BM02064H ↗
18. 10.1038/jcbfm.2011.4810.1038/jcbfm.2011.48 ↗
19. 10.1186/cc1372610.1186/cc13726 ↗
20. 10.1093/nar/gkg13710.1093/nar/gkg137 ↗
21. 10.1016/j.addr.2008.05.00310.1016/j.addr.2008.05.003 ↗
22. 10.1016/j.pharmthera.2019.10741810.1016/j.pharmthera.2019.107418 ↗
23. 10.1186/cc909810.1186/cc9098 ↗
24. 10.1146/annurev-pathol-012513-10465110.1146/annurev-pathol-012513-104651 ↗
25. 10.1016/j.cell.2021.06.02810.1016/j.cell.2021.06.028 ↗
26. 10.1146/annurev-immunol-031210-10140510.1146/annurev-immunol-031210-101405 ↗
27. 10.1038/s41577-019-0165-010.1038/s41577-019-0165-0 ↗
28. 10.1038/nri.2016.5810.1038/nri.2016.58 ↗
29. 10.1016/j.tibs.2016.10.00410.1016/j.tibs.2016.10.004 ↗
30. 10.1016/j.immuni.2018.07.00610.1016/j.immuni.2018.07.006 ↗
31. 10.1002/adma.20190726710.1002/adma.201907267 ↗
32. 10.1016/j.biomaterials.2020.12014210.1016/j.biomaterials.2020.120142 ↗
33. 10.1007/s00011-020-01423-010.1007/s00011-020-01423-0 ↗
34. 10.1002/anie.20201028110.1002/anie.202010281 ↗
35. 10.1021/acsnano.8b0402210.1021/acsnano.8b04022 ↗
36. 10.1039/C8NR00838H10.1039/C8NR00838H ↗
37. 10.1038/nature1055810.1038/nature10558 ↗
38. 10.1038/nature1551410.1038/nature15514 ↗
39. 10.1038/nature1862910.1038/nature18629 ↗
40. 10.1016/j.immuni.2021.01.00710.1016/j.immuni.2021.01.007 ↗
41. 10.1038/s41467-021-22987-310.1038/s41467-021-22987-3 ↗